Cost analysis of individualised dosing of omalizumab for the treatment of patients with chronic urticaria. Murray C, Ridge K, Conlon N. Eur J Dermatol 2023;33:561-562.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Murray C, Ridge K, Conlon N. Cost analysis of individualised dosing of omalizumab for the treatment of patients with chronic urticaria. Eur J Dermatol 2023;33:561-562.
PMID: 38297938